Cypher Revenue Stream Counters Some DES Damage To Guidant Stent Sales
This article was originally published in The Gray Sheet
Executive Summary
Guidant's co-promotion and catheter supply agreements with Cordis generated revenue of $21 mil. in Q1, slightly assuaging the impact of drug-eluting stents on bare-metal sales